248 related articles for article (PubMed ID: 16437496)
1. Drug treatment for myotonia.
Trip J; Drost G; van Engelen BG; Faber CG
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004762. PubMed ID: 16437496
[TBL] [Abstract][Full Text] [Related]
2. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
[TBL] [Abstract][Full Text] [Related]
3. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Moore DH; Barnes PR; Miller RG
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003218. PubMed ID: 16855999
[TBL] [Abstract][Full Text] [Related]
4. A review of the use of mexiletine in patients with myotonic dystrophy and non-dystrophic myotonia.
D'Mello S; Shum L
Eur J Hosp Pharm; 2016 Nov; 23(6):359-363. PubMed ID: 31156883
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine in the treatment of myotonia in myotonic dystrophy.
Grant R; Sutton DL; Behan PO; Ballantyne JP
J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):199-206. PubMed ID: 3553433
[TBL] [Abstract][Full Text] [Related]
8. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Miller R; Barnes P
Cochrane Database Syst Rev; 2002; (4):CD003218. PubMed ID: 12519589
[TBL] [Abstract][Full Text] [Related]
9. Strength training and aerobic exercise training for muscle disease.
Voet NB; van der Kooi EL; Riphagen II; Lindeman E; van Engelen BG; Geurts AC
Cochrane Database Syst Rev; 2013 Jul; (7):CD003907. PubMed ID: 23835682
[TBL] [Abstract][Full Text] [Related]
10. Strength training and aerobic exercise training for muscle disease.
van der Kooi EL; Lindeman E; Riphagen I
Cochrane Database Syst Rev; 2005 Jan; (1):CD003907. PubMed ID: 15674918
[TBL] [Abstract][Full Text] [Related]
11. Strength training and aerobic exercise training for muscle disease.
Voet NB; van der Kooi EL; Riphagen II; Lindeman E; van Engelen BG; Geurts ACh
Cochrane Database Syst Rev; 2010 Jan; (1):CD003907. PubMed ID: 20091552
[TBL] [Abstract][Full Text] [Related]
12. Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
Rana F; Gormez A; Varghese S
Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
[TBL] [Abstract][Full Text] [Related]
14. A pilot controlled study of the use of imipramine to reduce myotonia.
Gascon GG; Staton RD; Patterson BD; Konewko PJ; Wilson H; Carlson KM; Brumback RA
Am J Phys Med Rehabil; 1989 Oct; 68(5):215-20. PubMed ID: 2803681
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine for neuropathic pain in adults.
Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
[TBL] [Abstract][Full Text] [Related]
16. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
20. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
